Risk of Non-arteritic Anterior Ischemic Optic Neuropathy in Patients with Type 2 Diabetes and Obesity Using GLP-1 Receptor Agonists: A Cohort Study (S14.004)
To assess the risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients with type 2 diabetes mellitus (T2DM) and obesity using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to those not receiving these medications.
Authors
- Diogo Haddad Santos (ORCID: https://orcid.org/0000-0003-1474-1849)
- Mário Luiz Ribeiro Monteiro (ORCID: https://orcid.org/0000-0002-7281-2791)
- Dillan Cunha Amaral (ORCID: https://orcid.org/0009-0002-7948-154X)
- Ricardo Noguera Louzada (ORCID: https://orcid.org/0000-0002-9610-5768)
- Filipi Fim Andreão (ORCID: https://orcid.org/0000-0002-5961-4520)
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Hospital Alemão Oswaldo Cruz (BR)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212637
- Citations
- 1
- Primary Topic
- Intraoperative Neuromonitoring and Anesthetic Effects
- Type
- article
- Field-Weighted Citation Impact
- 2.01